These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4257050)

  • 21. Comparative study on identification for fibrinogen in human plasma and its preparations.
    Yasuda J; Miura Y; Abe T
    Nihon Ketsueki Gakkai Zasshi; 1972 Feb; 35(1):101-12. PubMed ID: 4629046
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serological characteristics of fibrin degradation products in human fluid plasma].
    Miura Y; Yasuda J; Abe H
    Rinsho Byori; 1971 Aug; 19():Suppl:257. PubMed ID: 5167953
    [No Abstract]   [Full Text] [Related]  

  • 23. The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage.
    Marder VJ; Shulman NR; Carroll WR
    Trans Assoc Am Physicians; 1967; 80():156-67. PubMed ID: 4230117
    [No Abstract]   [Full Text] [Related]  

  • 24. Radioimmunoassay of fibrinogen and its proteolysis products.
    Catt KJ; Hirsh J; Castelan DJ; Niall HD; Tregear GW
    Thromb Diath Haemorrh; 1968 Nov; 20(1):1-6. PubMed ID: 4236937
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of FDP (fibrinogen degradation products) determination by erythrocyte agglutination inhibition reaction].
    Watanabe K; Usuda F; Fukui R; Sugita H
    Rinsho Byori; 1971 Aug; 19():Suppl:255. PubMed ID: 5290294
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterization of the terminal degradation products of canine fibrinogen by plasmin.
    Chen JP; Hutchison HT; Nanninga LB; Guest MM
    Biochim Biophys Acta; 1975 Mar; 386(1):69-79. PubMed ID: 123781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of serum fibrinogen and fibrin degradation products. Comparison of six technics using purified products and application in clinical studies.
    Marder VJ; Matchett MO; Sherry S
    Am J Med; 1971 Jul; 51(1):71-82. PubMed ID: 4998883
    [No Abstract]   [Full Text] [Related]  

  • 28. The measurement of fibrinogen and its derivatives. II. Determination of total immunoreactive fibrinogen in the presence of soluble fibrin monomer complexes (cryoprofibrin complexes).
    Farrell GW; Wolf P
    Med Lab Technol; 1971 Jul; 28(3):319-27. PubMed ID: 4254371
    [No Abstract]   [Full Text] [Related]  

  • 29. [Study of the fibrin degradation products in the synovial fluid of rheumatological diseases (author's transl)].
    Kolodie L; Phelipp X; Baccard C
    Sem Hop; 1980 May 8-15; 56(17-18):832-6. PubMed ID: 6248965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophoretic pattern and reactivity of fibrinogen degradation products (FDP) in three assays.
    Niewiarowski S; Nandi M; Colman RW; Bloch KJ
    Scand J Haematol Suppl; 1971; 13():129-35. PubMed ID: 4258198
    [No Abstract]   [Full Text] [Related]  

  • 31. Nature of the high molecular weight fraction of fibrinolytic digests of human fibrinogen.
    Jamieson GA; Gaffney PJ
    Biochim Biophys Acta; 1968 Jan; 154(1):96-109. PubMed ID: 4230213
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
    Chen JP; Williams TK; Legendre AM
    Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of staphylococcal clumping test and its clinical application].
    Nakazawa S; Meguro T; Yamada Z; Yamada K
    Rinsho Ketsueki; 1972 Jun; 13(3):363-9. PubMed ID: 4674966
    [No Abstract]   [Full Text] [Related]  

  • 34. Fibrinogen breakdown products: identification and assay in serum and urine.
    Rayner H; Parashevas F; Israels LG; Israels ED
    J Lab Clin Med; 1969 Oct; 74(4):586-96. PubMed ID: 4241717
    [No Abstract]   [Full Text] [Related]  

  • 35. Assay of IgG and other human plasma proteins by quantitative inhibition of passive hemagglutination.
    Nusbacher J; Berkman EM; Wong KY; Kochwa S; Rosenfield RE
    J Immunol; 1972 Apr; 108(4):893-902. PubMed ID: 4623399
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of polyacrylamide gel as an immunoadsorbent for anti-2,4-dinitrophenyl antibodies.
    Jaquet H; Havas HF
    J Immunol; 1971 Dec; 107(6):1729-37. PubMed ID: 5000990
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunological quantitative method for fibrinolytic split products and its clinical use].
    Seo M
    Nihon Ketsueki Gakkai Zasshi; 1969 Jun; 32(3):406-16. PubMed ID: 4243119
    [No Abstract]   [Full Text] [Related]  

  • 38. Measurement of fibrinogen degradation products.
    Cohen RJ
    N Engl J Med; 1970 Dec; 283(26):1465-6. PubMed ID: 5481782
    [No Abstract]   [Full Text] [Related]  

  • 39. [Fibrinogen degradation products in kidney diseases. Preliminary note].
    Barboni F; Sasdelli M
    Boll Soc Ital Biol Sper; 1971 Sep; 47(17):503-6. PubMed ID: 5003816
    [No Abstract]   [Full Text] [Related]  

  • 40. [FDP (fibrinogen degradation products) determination by TRCHII (tanned red cell haemogglutination inhibition immunoassay) method].
    Abe K; Endo E; Kato M
    Rinsho Byori; 1971 Aug; 19():Suppl:256. PubMed ID: 5290295
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.